HOME > TOP STORIES
TOP STORIES
-
BUSINESS Moderna Ratchets Up Oncology Drive with Cancer Vaccine PIII Win
September 15, 2026
-
BUSINESS Taiho Takes Small-Molecule Expertise into ADCs; 3-Payload IND Due This Year
September 14, 2026
-
REGULATORY Japan Pharma Investment Subgroup to Hold 1st Meeting September 18
September 14, 2026
-
BUSINESS Former Takeda CEO Yasuchika Hasegawa Dies at 80
September 11, 2026
-
BUSINESS Takeda R&D Chief Plump to Retire in June 2027
September 11, 2026
-
BUSINESS Ex-Takeda CEO Weber Joins Rakuten Medical as Vice Chairman
September 10, 2026
-
REGULATORY MHLW to Weigh Survey Data, Past Approach for FY2027 Revision: Official
September 10, 2026
-
REGULATORY Chuikyo Reps Back Greater Transparency, but Lean toward Broader CEA Price Cuts
September 10, 2026
-
BUSINESS 3 Chugai Researchers Win Lasker Award for Hemlibra Discovery
September 10, 2026
-
BUSINESS Medipal Names Imagawa as New CEO in 1st Leadership Change in 14 Years
September 9, 2026
-
REGULATORY PMDA Generic GMP Inspections a Real-World Test to Stem Startup Risks: Official
September 8, 2026
-
REGULATORY CEA Review Finds Past Decisions Sound, Sees Room for More Transparency
September 8, 2026
-
COMMENTARY As US Pushes Global Cost Rebalancing, Can Japan Answer with Drug Prices?
September 7, 2026
-
REGULATORY LDP Panel Chief Calls for Earlier CGP Coverage in Cancer Care
September 4, 2026
-
BUSINESS Fuji Curbs Shipments of Simponi, Ranmark Biosimilars Soon after Launch
September 4, 2026
-
REGULATORY Japan to Revisit Handling of Steroid Creams under OTC-Like Drug Charge
September 4, 2026
-
ACADEMIA Generic Shortage Response Evolves into Wakayama’s 1st Regional Formulary
September 3, 2026
-
REGULATORY New MHLW Pharma Chief Puts AI in Regulatory Reviews High on Agenda
September 3, 2026
-
REGULATORY MHLW Lines Up 32.6 Billion Yen for 4 New Drug Discovery Support Projects
September 2, 2026
-
REGULATORY Astellas, Kyowa Kirin 1st Japan Pharmas to Cut US MFN Deals
September 1, 2026
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
